Distribution of immune cell subsets and cytokine-producing cells in the uterine cervix of human papillomavirus (HPV)-infectecl women: Influence of HIV-1 coinfection

Diagnostic Molecular Pathology

Volumn 14, Issue 1, 2005, Pages 39-47

  Nicol, Alcina Frederica ^a   Gomes Fernandes, Ana Teresa ^a   Grinsztejn, Beatriz ^a   Russomano, Fabio ^a   Lapa E Silva, José Roberto ^b   Tristão, Aparecida ^a   De Andrade Pérez, Mauricio ^a   Nuovo, Gerard J ^c   Martínez Maza, Otoniel ^d   Bonecini Almeida, Maria Da Gloria ^a  

^a INSTITUTO OSWALDO CRUZ   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c University Hospital   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cervical immune response; Cytokine; HIV 1; HPV; In situ PCR

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; CHLORDANE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER RISK; CELL INFILTRATION; CELLULAR IMMUNITY; CLINICAL ARTICLE; COLPOSCOPY; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE LOCATION; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCHEMISTRY; IMMUNOCOMPETENCE; IMMUNOCOMPETENT CELL; INFLAMMATORY CELL; MACROPHAGE ACTIVATION; NUCLEIC ACID ANALYSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RISK FACTOR; T LYMPHOCYTE; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; VIRUS INFECTION; VIRUS TRANSMISSION; WART VIRUS;

ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CERVIX UTERI; CYTOKINES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE SUBSETS; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL DISEASES;

EID: 20044388320     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000143309.81183.6c     Document Type: Article

References (51)

1. IARC Working Group. IARC monographs on the evaluation of carcinogenic risks to humans. London: Oxford Univ. Press, 1995:64.
2. Walboomers JMM, Jacobs MV, Manos MM, et al. Human Papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189:12-19.
3. Tweddel G, Heller P, Cunnane M, et al. The correlation between HIV seropositivity, cervical dysplasia and HPV subtypes 6/11, 16/18, 31/33/35. Gynecol Oncol. 1994;52:161-164.
4. Clarke B, Chetty R. Postmodern cancer: The role of human immunodeficiency virus in uterine cervical cancer. Review Mol Pathol. 2002;55:19-24.
5. Poli G, Bressler P, Kinter A, et al. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor α by transcriptional and posttranscriptional mechanisms. J Exp Med. 1990;172:151-158.
6. Gage JR, Sandhu AK, Nihira M, et al. Cervical cancer cell lines and human papillomavirus (HPV)-Immortalized keratinocytes induce HIV-1 in the U1 monocyte line. J Obstet Gynecol. 2000;96:879-885.
7. Tay SK, Jenkins D, Maddox P, et al. Lymphocyte phenotype in cervical intraepithelial neoplasia and human papillomavirus infection. Br J Obstet Gynaecol. 1987b;94:16-21.
8. Kobayashi A, Darragh T, Herndier B, et al. Lymphoid follicles are generated in high-grade cervical dysplasia and have differing characteristics depending on HIV status. Am J Pathol. 2002;160:151-164.
9. Manetti R, Annunziato F, Gianno V, et al. 1996. Th1 and Th2 Cells in HIV Infection. In: Romagnani S (ed): Th1 and Th2 in Health and Disease. Chem Immunol Basel Karger 63:138-157.
10. Arany I, Muldrow M, Trying SK. Correlation between mRNA levels of IL-6 and TNF-α and progression rate in anal squamous epithelial lesions from HIV-positive men. Antic Res. 2001;21:425-428.
11. Arany I, Tyring SK. Activation of local cell-mediated immunity in interferon-responsive patients with human papillomavirus-associated lesions. J Interferon Cytokine Res. 1996;16:453-460.
12. Al-Saleh W, Giannini SL, Jacobs N, et al. Correlation of T-Helper secretory differentiation and types of antigen-presenting cells in squamous intraepithelial lesions of the uterine cervix. J Pathol. 1998;184: 283-290.
13. Belec L, Gherardi R, Payan C, et al. Proinflammatory cytokine expression in cervicovaginal secretions of normal and HIV-infected women. Cytokine. 1995;7:568-574.
14. Olaitan A, Johnson MA, MacLean A, et al. The distribution of immunocompetent cells in the genital tract of HIV-positive women. AIDS. 1996; 10:759-764.
15. Schafer A, Friedmann W, Mielke M, et al. The increased frequency of cervical dysplasia-neoplasia in women infected with the human immunodeficiency virus is related to the degree of immunosuppression. Am J Obstet Gynecol. 1991;164:593-599.
16. Garzetti GG, Ciavattini A, Butini L, et al. Cervical dysplasia in HIV-seropositive women: Role of human papillomavirus infection and immune status. Gynecol Obstet Invest. 1995;40:52-56.
17. Iglesias M, Plowman GD, Woodworth CG. Interleukin-6 and interleukin-6 soluble receptor regulete proliferation of normal, human papillomavirus- immortalized, and carcinoma-derived cervical cells in vitro. Am J Pathol. 1995;146:944-952.
18. Clerici M, Merola M, Ferrario E, et al. Cytokine production patterns in cervical intraepithelial neoplaisa: association with human papillomavirus infection. J Natl Cancer Inst. 1997;89:245-250.
19. Castrilli G, Tatone D, Diodoro MG, et al. Interleukin- 1 α and interleukin-6 promote the in vitro growth of both normal and neoplastic human cervical epithelial cells. Br J Cancer. 1997;75:855-859.
20. Tsukui T, Hildesheim A, Schiffman MH, et al. Interleukin 2 production in vitro by peripheral lymphocytes in response to human papillomavirus-derived peptides: Correlation with cervical pathology. Cancer Res. 1996; 56:3967-3974.
21. Hess S, Smola H, Silva EU, et al. Loss of IL-6 receptor expression in cervical carcinoma cells inhibits autocrine IL-6 stimulation: Abrogation of constitutive monocyte chemoattractant protein-1 production. J Immunol. 2000;165:1939-1948.
22. Wei LH, Kuo ML, Chen CA, et al. Interleukin-6 in cervical cancer; the relationship with vascular endothelial growth factor. Gynecol Oncol. 2001;82:49-56.
23. de Gruijl TD, Bontkes HJ, Van den Muysenberg AJC, et al. Differences in cytokine mRNA profiles between premalignant and malignant lesions of the uterine cervix. Eur J Cancer. 1999;35:490-497.
24. Tartour E, Gey A. Sastre-Garau, Lombardi SE, Mosseri V, Fridman H. Prognostic value of intratumoral interferon gamma messanger RNA expression in invasive cervical carcinomas. J Natl Cancer Inst. 1998; 90:287-294.
25. Crowley-Nowick PA, Ellenberg JH, Vermund SH, et al. Cytokine profile in genital tract secretions from female adolescents: Impact of human immunodeficiency virus, Human papillomavirus, and other sexually transmitted pathogens. J Infect Dis. 2000;181:939-945.
26. Passmore JA, Burch VC, Shepard EG, et al. Single-cell cytokine analysis allows detection of cervical T-cell responses against human papillomavirus type 16 L1 in woman infected with genital HPV J Med Virol. 2002;67:234-240.
27. Lopez MC, Stanley MA. Cytokine profile of draining lymph node lymphocytes in mice grafted with syngeneic keratinocytes expressing human papillomavirus type 16 E7 protein. J Gen Virol. 2000;81:1175-1182.
28. Santin AD, Ravaggi A, Bellone S, et al. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix. Gynecol Oncol. 2001;81:424-432.
29. Coleman N, Birley HDL, Renton NP, et al. Immunological events in regressing warts. Am J Clin Pathol. 1994;102:768-774.
30. Tay SK, Jenkins D, Maddox P, et al. Lymphocyte phenotype in cervical intraepithelial neoplasia and human papillomavirus infection. Br J Obstet Gynaecol. 1987b;94:16-21.
31. Viac J, Guérin-Reverchon I, Chardonnet Y, et al. Langerhans cells and epithelial cell modifications in cervical intraepithelial neoplasia: Correlation with human papillomavirus infection. Immunobiology. 1990; 180:328-338.
32. Davidson B, Gold I, Kopolovic J. Inflammatory response in cervical intraepithelial neoplasia and squamous cell carcinoma of the uterine cervix. Pathol Res Pract. 1997;193:491-495.
33. Giannini SL, Hubert P, Doyen J, et al. Influence of the mucosal epithelium microenvironment on langerhans cells: implications for the development of squamous intraepithelial lesions of the cervix. Int J Cancer. 2002;97: 654-659.
34. Richart RM. A modified terminology for cervical intraepithelial neoplasia. Obstet Gynecol. 1990;75:131-133.
35. Sander B, Damm O, Gustafsson B, et al. Localization of IL-1, IL-2, IL-4, IL-8 and TNF in superficial bladder tumors treated with intravesical bacillus Calmette-Guerin. J Urol. 1996;156:536-541.
36. + cells from virus binding. J Exp Med. 1990;172:1233.
37. lck) that phosphorylates the CD3 complex. Proc Natl Acad Sci U S A. 1989;86:3277-3281.
38. Spiteri MA, Clarke SW, Poulter LW. Alveolar macrophages that suppress T-cell responses may be crucial to the pathogenetic outcome of pulmonary sarcoidosis. Eur Respir J. 1992;5:394-403.
39. Hogg N, MacDonald S, Slusarenko M, et al. Monoclonal antibodies specific for human monocyes, gmulocytes and endothelium. Immunology. 1984;53:753-766.
40. Nuovo GJ, Forde A, MacConnell P, et al. In situ detection of PCR-amplified HIV-1 nucleic acids and tumor necrosis factor cDNA in cervical tissues. Am J Pathol. 1993;143:40-48.
41. Nuovo GJ, Becker J, Burke M, etal. In situ dectection of PCR-amplifiedHIV-1 nucleic acids in lymph nodes and peripheral blood in asymptomatic infection and advanced stage AIDS. J Acquired Immun Def. 1994;7:916-923.
42. rd ed. New York, Raven Press 1996.
43. Barberis MC, Vago L, Cecchini G, et al. Local impairment of immunoreactivity in HIV-infected women with HPV-related squamous intraepithelial lesions of the cervix. Tumori. 1998;84:489-492.
44. Olaitan A, Johnson MA, MacLean A, et al. The distribution of immunocompetent cells in the genital tract of HIV-positive women. AIDS. 1996;10:759-764.
45. + patients have increased lymphocyte infiltrates in CIN lesions. Gynecol Oncol. 2000;76:315-319.
46. Kleine-lowinski K, Gillitzer R, Kühne-Heid R, et al. Monocyte-chemoattractant-protein-1 (MCP-1)-gene expression cervical intra-epithelial neoplasias and cervical carcinomas. Int J Cancer. 1999;82:6-11.
47. Yarchoan R, Redfield RR, Broder S. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus. J Clin Invest. 1986;78:439-447.
48. Martinez-Maza O, Crabb E, Mitsuyasu RT, et al. Infection with the human immunodeficiency virus (HIV) is associated with an in vivo increase in B lymphocyte activation and immaturity. J Immunol. 1987;138:3720-3724.
49. Breen EC, Rezai AR, Nakajima K, et al. Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 1999;144:480-484.
50. Tjiong MY, Vange NV, Kate FJW, et al. Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer. Gynecol Oncol. 1999;73:285-291.
51. Lee BN, Follen M, Tortolero-Luna G, et al. Synthesis of IFN-γ by CD8+ T cells is preserved in HIV-infected women with HPV-related cervical squamous intraepithelial lesions. Gynecol Oncol. 1999;75:379-386.